Page last updated: 2024-12-07
deriphyllin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 122562 |
SCHEMBL ID | 8494464 |
MeSH ID | M0076897 |
Synonyms (12)
Synonym |
---|
32156-80-2 |
deriphyllin |
hydroxyethyltheophylline complet |
theophylline diethanolamine |
x3d62bxx1r , |
unii-x3d62bxx1r |
theophylline diethanolamine [mi] |
SCHEMBL8494464 |
1,3-dimethyl-7h-purine-2,6-dione;2-(2-hydroxyethylamino)ethanol |
Q27293506 |
1,3-dimethyl-3,9-dihydro-1h-purine-2,6-dione--2,2'-azanediyldi(ethan-1-ol) (1/1) |
DTXSID90954028 |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
"In rabbits, a three way cross-over test was carried out to assess bioavailability of digoxin from commercially available 'Deriphyllin-Digoxin' tablets." | ( Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model. Bansinath, M; Chopra, KS; Ghosh, SS; Mathur, VS; Shukla, VK, 1986) | 0.75 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 103.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (103.56) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (20.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |